20103 ⎘
Medicinal preparations characterised by special physical form; Pills, tablets, discs, rods; Excipients; Inactive ingredients; Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Tolperisone-containing pharmaceutical preparation with controllable active-substance release for oral administration
#3002Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
#3003Tablets with improved drug substance dispersibility
#3004Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
#3005Abuse-proofed dosage form
#3006CONTROLLED RELEASE LIPOIC ACID
#3007Vaginally administrable progesterone containing tablets and method for preparing the same
#3008Process for the production of an abuse-proofed dosage form
#3009Orally bioavailable CCI-779 formulations
#3010Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
#3011Tabletting process
#3012Bambuterol and integrin inhibitor combination and treatment method
#3013Sustained release pharmaceutical formulations
#3014Chitosan-base antimicrobial thermoplastic polymer blends
#3015Methods and compositions for deterring abuse of orally administered pharmaceutical products
#3016Sustained-release tramadol formulations with 24-hour clinical efficacy
#3017Medicinal table with prolonged release of the active principle
#3018Controlled release oxycodone compositions
#3019Controlled release oxycodone compositions
#3020Solid compositions comprising gabapentin having improved stability
#3021Novel method stabilizing bupropion hydrochloride tablets
#3022Medical devices containing crazed polymeric release regions for drug delivery
#3023Matrix type sustained-release preparation containing basic drug or salt thereof
#3024Extended release matrix tablets
#3025Controlled release and taste masking oral pharmaceutical composition
#3026Pharmaceutical compositions comprising amoxicillin and clavulanic acid
#3027Sustained-release preparations and method for producing the same
#3028Solid formulation with improved solubility and stability, and method for producing said formulation
#3029Sustained release compositions containing alfuzosin
#3030Sustained release ranolazine formulations
#3031Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
#3032GABA analog prodrug sustained release oral dosage forms
#3033Oral administration of calcitonin
#3034Controlled release and taste masking oral pharmaceutical composition
#3035Tranexamic acid formulations with reduced adverse effects
#3036Nateglinide-containing preparation
#3037System and method for producing a directly compressible, high-potency formulation of metformin hydrochloride
#3038Oral solid dosage forms containing a low dose of estradiol
#3039Deferacirox dispersible tablets
#3040Methods and compositions for deterring abuse of orally administered pharmaceutical products
#3041Stabilization of quinapril using magnesium oxide
#3042Methods and formulations for making controlled release oral dosage form
#3043Methods and formulations for making controlled release oral dosage form
#3044Controlled release oxycodone compositions
#3045Sustained release drug delivery system and method
#3046Agent delivery system
#3047Highly compressible controlled delivery compositions of metformin
#3048Combination therapy for treating viral infections
#3049Stabilization of the profile of release of active substances from a formulation
#3050Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
#3051Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
#3052Chewable enteric coated aspirin tablets
#3053Dry polymer and lipid composition
#3054Process for preparing poly (vinyl alcohol) drug delivery devices with humidity control
#3055Class of surfactant-like materials
#3056Pharmaceutical compositions for the treatment of hyper-proliferative disorders
#3057Controlled release oxycodone compositions
#3058Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
#3059Stable pharmaceutical formulations
#3060Gabapentin tablets and method for their preparation
#3061Direct compression polymer tablet core
#3062Sustained release L-arginine formulations and methods of manufacture and use
#3063Solid formulation
#3064Methods for manufacturing delivery devices and devices thereof
#3065Controlled release alpha lipoic acid formulation with an inositol compound
#3066Antimicrobial mesoporous silica nanoparticles
#3067Compression formed preparation and method for manufacturing same
#3068Galenic formulations of organic compounds
#3069Immediate release pharmaceutical formulation
#3070Combination immediate release controlled release levodopa/carbidopa dosage forms
#3071Rapidly disintegrating enzyme-containing solid oral dosage compositions
#3072Controlled release metformin compositions
#3073Controlled release metformin compositions
#3074Controlled release metformin compositions
#3075Controlled release metformin compositions
#3076Delayed release formulations of 6-mercaptopurine
#3077Tibolone-adsorbates
#3078Nitrofurantoin controlled release dosage form
#3079Abuse-proofed oral dosage form
#3080Methods of treating various conditions by administration of sustained release L-arginine
#3081Methods of treating various conditions by administration of sustained released L-Arginine
#3082Sustained release L-arginine formulations and methods of manufacture and use
#3083Solid preparation
#3084Solid dosage form for acid-labile active ingredient
#3085Promethazine containing dosage form
#3086Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers
#3087Sustained release formulations of guaifenesin and additional drug ingredients
#3088Oral delivery system
#3089Galenic formulations of organic compounds
#3090Carvedilol-hydrophilic solutions
#3091Pharmaceutical composition containing irbesartan
#3092Sustained release propafenone hydrochloride capsules
#3093Solid-state form of celecoxib having enhanced bioavailability
#3094Celecoxib compositions
#3095High drug load tablet
#3096Modified release dosage forms
#3097Omeprazole dosage form
#3098Fast disintegrating granules containing bromhexin/bromhexinhydrochloride, process for their preparation, and their use in veterinary medicine
#3099Direct compression polymer tablet core
#3100Sustained release, mucoadhesive vaginal pharmaceutical compositions
#3101Directly compressible tricalcium phosphate
#3102Composition for enhancing absorption of a drug and method
#3103Tranexamic acid formulations
#3104Rapidly disintegrating tablets comprising calcium carbonate
#3105Rapidly disintegrating tablets comprising titanium dioxide
#3106Oral care products comprising calcium phosphates
#3107Multiblock biodegradable hydrogels for drug delivery and tissue treatment
#3108Modified-release tablet of bupropion hydrochloride
#3109Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
#3110Donepezil formulations
#3111Process for preparing oral calcium compositions
#3112Orally disintegrating tablets and methods of manufacture
#3113Sustained-release tablet formulation
#3114Methods and compositions for improving drug safety
#3115Method of treating amyloid beta precursor disorders
#3116Multivitamin formulations containing controlled-release magnesium
#3117Tablet formulations comprising valsartan
#3118Immediate release tablet
#3119Pharmaceutical composition having a delayed active substance release, and method for the preparation thereof
#3120Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
#3121Storage stable tablets of fosinopril sodium
#3122Tolperisone-containing pharmaceutical preparation with controllable active-substance release for oral administration
#3123Compositions comprising vitamin E and saw palmetto
#3124Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
#3125Galantamine formulations
#3126Taste-masking oral dosage form and method of preparing the same
#3127Pharmaceutical formulations
#3128Compositions of estrogen-cyclodextrin complexes
#3129Composition and method for enhancing bioavailability
#3130Vaginally administrable progesterone-containing tablets and method for preparing same
#3131Carbonyl iron pharmaceutical dosage forms for the treatment of iron-deficiency anemia
#3132Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
#3133Sustained release torsemide dosage forms
#3134Controlled release dosage forms using acrylic polymer, and process for making
#3135Ziprasidone formulations
#3136Method of preparing low-crystallinity oltipraz or amorphous oltipraz
#3137Rosiglitazone and metformin formulations
#3138Rosiglitazone formulations
#3139Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
#3140Sustained release oral dosage forms of gabapentin
#3141Sustained release ranolazine formulations
#3142Atomoxetine formulations
#3143Salts of fenofibric acid and pharmaceutical formulations thereof
#3144Systems, methods and apparatuses for manufacturing dosage forms
#3145Oral disintegrating dosage forms
#3146Solid pharmaceutical dosage formulation
#3147Galantamine formulations
#3148Novel composition and use
#3149Extended release tablet formulations of venlafaxine
#3150Colonic purgative composition with soluble binding agent
#3151Systems, methods and apparatuses for manufacturing dosage forms
#3152Process for producing solid dosage forms
#3153Method and apparatus for transferring substrates
#3154Pharmaceutical compositions
#3155Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
#3156Extended release alpha-2 agonist pharmaceutical dosage forms
#3157Pharmaceutical composition for oral use with improved absorption
#3158Methods and compositions for deterring abuse of opioid containing dosage forms
#3159Controlled release arginine α-ketoglutarate
#31605-Ht4partial agonist pharmaceutical compositions
#3161Pharmaceutical superdisintegrant
#3162Pharmaceutical formulation containing muscle relaxant and COX-II inhibitor
#3163Compositions comprising fenofibrate and rosuvastatin
#3164Compositions comprising fenofibrate and pravastatin
#3165Fosinopril composition
#3166Melt-extruded orally administrable opioid formulations
#3167Pharmaceutical formulation containing dye
#3168Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
#3169New process 1
#3170Dosage form, device, and methods of treatment
#3171Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
#3172Sustained release ranolazine formulations
#3173Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
#3174Extended release systems for macrolide antibiotics
#3175Antibiotic product, use and formulation thereof
#3176Solid pharmaceutical dosage form
#3177Compositions and dosage forms for gasteric delivery of antineoplastic agents and methods of treatment that use them to inhibit cancer cell proliferation
#3178Controlled release pharmaceutical formulation containing venlafaxine
#3179Bioresorbable hydrogel compositions for implantable prostheses
#31803,7-Diazabicyclo [3.3.1]formulations as anti-arrhythmic compounds
#3181Ginger extract preparation
#3182Implantable polymeric device for sustained release of nalmefene
#3183Abuse-proofed dosage form
#3184Controlled drug release tablets
#3185Tranexamic acid formulations with reduced adverse effects
#3186Composite dosage forms
#3187Controlled release solid dispersions
#3188Flashmelt oral dosage formulation
#3189Pharmaceutical composition as solid dosage form and method for manufacturing thereof
#3190Dual drug dosage forms with improved separation of drugs
#3191Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt
#3192Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems
#3193Saquinavir mesylate oral dosage form
#3194Vaginally administratable progesterone-containing tablets and method for preparing same
#3195Bicalutamide compositions
#3196Telmisartan sodium salt pharmaceutical formulation
#3197Extended-release pharmaceutical compositions of Ralinepag
#3198Pharmaceutical composition of darolutamide
#3199Methods of treating migraines with a combination of a meloxicam and a rizatriptan
#3200Oral brexanolone compositions and methods of preparation and use
#3201Solid forms of macrocyclic compounds, salts and formulations thereof, and methods of preparing and using the same
#3202Pharmaceutical formulations and uses thereof
#3203Sublingual Semaglutide-BPC 157 combination for weight loss
#3204Combination of dextromethorphan and bupropion for treating depression
#3205Buccal formulation of avanafil with enhanced bioavailability and prolonged duration
#3206Compounds and combinations thereof for treating neurological and psychiatric conditions
#3207Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan
#3208Bupropion dosage forms with reduced food and alcohol dosing effects
#3209Buccal formulation of avanafil with enhanced bioavailability and prolonged duration
#3210Tablet for oral suspension
#3211Extended release amphetamine tablets
#3212Self-nanoemulsifying 3D-printed tablet composition and method of use thereof
#3213Elagolix formulation
#3214Extended release compositions comprising pyridostigmine
#3215Liquisolid tablet containing combined dose of tadalafil and dapoxetine
#3216Methods of treatment comprising torsemide
#3217Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor
#3218Sustained release metoprolol formulations
#3219Anti-overingestion dosage forms
#3220Extended release pharmaceutical formulations with controlled impurity levels
#3221Extended release pharmaceutical formulations
#3222Sustained release metoprolol formulations
#3223Pharmaceutical composition of doxycycline
#3224Film composition and methods for producing the same
#3225Method for treating primary insomnia